Klaus Bendtzen - Publications, H-index & Citations

Klaus Bendtzen

sahlgrenska university hospital

78H指数

730论文数

2.2W被引数

收录论文 120

发表时间

Sulfatide inhibits fibroblast growth, activation and oxidative stress induced by ectopic insulin

DIABETES OBESITY & METABOLISM

IF5.7

2023-05-29

OAAI

Roeske-Nielsen, Allan; Mansson, Jan-Eric; Tekin, Hasim; Rieneck, Klaus; Bendtzen, Klaus; Buschard, Karsten

Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies SARS-CoV-2感染的转录景观消除了病毒激活的致病途径，提出了独特的性别特异性差异，并预测了量身定制的治疗策略

AUTOIMMUNITY REVIEWS

IF8.3

2020-07-01

OAAI

Fagone, Paolo; Ciurleo, Rosella; Lombardo, Salvo Danilo; Iacobello, Carmelo; Palermo, Concetta Ilenia; Shoenfeld, Yehuda; Bendtzen, Klaus; Bramanti, Placido; Nicoletti, Ferdinando

The cytokine network in the pathogenesis of major depressive disorder. Close to translation?

AUTOIMMUNITY REVIEWS

IF8.3

2020-05-01

PREAI

Petralia, Maria Cristina; Mazzon, Emanuela; Fagone, Paolo; Basile, Maria Sofia; Lenzo, Vittorio; Quattropani, Maria Catena; Nuovo, Santo Di; Bendtzen, Klaus; Nicoletti, Ferdinando

Personalized medicine in rheumatoid arthritis: How immunogenicity impacts use of TNF inhibitors

AUTOIMMUNITY REVIEWS

IF8.3

2020-05-01

PREAI

Bodio, Caterina; Grossi, Claudia; Pregnolato, Francesca; Favalli, Ennio Giulio; Biggioggero, Martina; Marchesoni, Antonio; Murgo, Antonella; Filippini, Matteo; Migliorini, Paola; Caporali, Roberto; Pellerito, Raffaele; Ciccia, Francesco; Sarzi-Puttini, Piercarlo; Perosa, Federico; Paolazzi, Giuseppe; Hollan, Ivana; Bendtzen, Klaus; Meroni, Pier Luigi; Borghi, Maria Orietta

Pathogenic contribution of the Macrophage migration inhibitory factor family to major depressive disorder and emerging tailored therapeutic approaches

JOURNAL OF AFFECTIVE DISORDERS

IF4.9

2020-02-01

OAAI

Petralia, Maria Cristina; Mazzon, Emanuela; Fagone, Paolo; Basile, Maria Sofia; Lenzo, Vittorio; Quattropani, Maria Catena; Bendtzen, Klaus; Nicoletti, Ferdinando

Lewis and AB0 blood group-phenotypes in periodontitis, cardiovascular disease, obesity and stroke

SCIENTIFIC REPORTS

IF3.9

2019-04-18

OAAI

Enevold, C.; Nielsen, C. H.; Molbo, D.; Lund, R.; Bendtzen, K.; Fiehn, N. -E.; Holmstrup, P.

Pattern recognition receptor polymorphisms in early periodontitis 早期牙周炎的模式识别受体多态性

JOURNAL OF PERIODONTOLOGY

IF3.8

2018-12-19

PREAI

Leite, Fabio R. M.; Enevold, Christian; Bendtzen, Klaus; Baelum, Vibeke; Lopez, Rodrigo

Gasotransmitters and the immune system: Mode of action and novel therapeutic targets

EUROPEAN JOURNAL OF PHARMACOLOGY

IF4.7

2018-09-01

PREAI

Fagone, Paolo; Mazzon, Emanuela; Bramanti, Placido; Bendtzen, Klaus; Nicoletti, Ferdinando

Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events

EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY

IF3.4

2017-08-14

PREAI

Prado, Monica Simon; Bendtzen, Klaus; Coelho Andrade, Luis Eduardo

Letter: can addition of an immunomodulator really reverse antibody formation and loss of response in patients treated with adalimumab?

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2017-02-02

OAAI

Bendtzen, K.; Steenholdt, C.

HIV-protease inhibitors for the treatment of cancer: Repositioning HIV protease inhibitors while developing more potent NO-hybridized derivatives?

INTERNATIONAL JOURNAL OF CANCER

IF4.7

2017-01-20

OAAI

Maksimovic-Ivanic, Danijela; Fagone, Paolo; McCubrey, James; Bendtzen, Klaus; Mijatovic, Sanja; Nicoletti, Ferdinando

Changes in Serum Trough Levels of Infliximab During Treatment Intensification but not in Anti-infliximab Antibody Detection are Associated with Clinical Outcomes after Therapeutic Failure in Crohn's Disease

JOURNAL OF CROHNS & COLITIS

IF8.7

2015-01-09

OAAI

Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jorn; Thomsen, Ole O.; Munck, Lars K.; Christensen, Lisbet A.; Pedersen, Gitte; Kjeldsen, Jens; Ainsworth, Mark A.

Clinical Implications of Measuring Drug and Anti-Drug Antibodies by Different Assays When Optimizing Infliximab Treatment Failure in Crohn's Disease: Post Hoc Analysis of a Randomized Controlled Trial

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2014-07-01

124

PREAI

Steenholdt, Casper; Bendtzen, Klaus; Brynskov, Jorn; Thomsen, Ole O.; Ainsworth, Mark A.

Genetic polymorphisms of dsRNA ligating pattern recognition receptors TLR3, MDA5, and RIG-I. Association with systemic lupus erythematosus and clinical phenotypes

RHEUMATOLOGY INTERNATIONAL

IF2.9

2014-04-10

PREAI

Enevold, C.; Kjaer, L.; Nielsen, C. H.; Voss, A.; Jacobsen, R. S.; Hermansen, M. L. F.; Redder, L.; Oturai, A. B.; Jensen, P. E.; Bendtzen, K.; Jacobsen, S.

Antibodies against infliximab are associated with increased risk of anti-adalimumab antibody development in patients with inflammatory bowel disease

JOURNAL OF CROHNS & COLITIS

IF8.7

2014-02-01

OAAI

Frederiksen, M. T.; Ainsworth, M. A.; Brynskov, J.; Thomsen, O. O.; Bendtzen, K.; Steenholdt, C.

Melatonin suppresses markers of inflammation and oxidative damage in a human daytime endotoxemia model 褪黑素抑制人类白天内毒素血症模型中的炎症和氧化损伤标志物

JOURNAL OF CRITICAL CARE

IF2.9

2014-02-01

PREAI

Alamili, Mahdi; Bendtzen, Klaus; Lykkesfeldt, Jens; Rosenberg, Jacob; Gogenur, Ismail

Clinical implications of measuring drug and anti-drug antibodies by different assays when optimizing infliximab treatment failure in Crohn's disease

JOURNAL OF CROHNS & COLITIS

IF8.7

2014-02-01

PREAI

Steenholdt, C.; Bendtzen, K.; Brynskov, J.; Thomsen, O. O.; Ainsworth, M. A.

Commentary: antibodies reacting with the infliximab Fab portion - something new? Authors' reply

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2013-08-13

PREAI

Nielsen, C. H.; Steenholdt, C.; Palarasah, Y.; Bendtzen, K.; Teisner, A.; Brynskov, J.; Teisner, B.

Pre-existing IgG antibodies cross-reacting with the Fab region of infliximab predict efficacy and safety of infliximab therapy in inflammatory bowel disease

ALIMENTARY PHARMACOLOGY & THERAPEUTICS

IF6.7

2013-05-07

OAAI

Steenholdt, C.; Palarasah, Y.; Bendtzen, K.; Teisner, A.; Brynskov, J.; Teisner, B.; Nielsen, C. H.

Comparison of Techniques for Monitoring Infliximab and Antibodies to Infliximab in Crohn's Disease Patients with Infliximab Treatment Failure

AMERICAN JOURNAL OF GASTROENTEROLOGY

IF7.6

2012-10-01

PREAI

Steenholdt, Casper; Brynskov, Jorn; Thomsen, Ole; Munck, Lars; Fallingborg, Jan; Christensen, Lisbet; Pedersen, Gitte; Kjeldsen, Jens; Bendtzen, Klaus; Lockton, Steven; Hauenstein, Scott; Shringarpure, Reshma; Chuang, Emil; Singh, Sharat; Ainsworth, Mark

研究方向